Background Gastric cancer is the third most common cause of cancer‐related mortality in the
world. Currently there are two surgical options for potentially curable patients (ie people with …

Gastrectomy is the mainstay treatment for gastric cancer. To reduce the associated patient
burden, minimally invasive gastrectomy was introduced in almost 30 years ago. The …

BACKGROUND The oncological efficacy and safety of laparoscopic gastrectomy are under
debate for the Western population with predominantly advanced gastric cancer undergoing …

Importance It is not clear whether laparoscopic and open distal gastrectomy produce similar
outcomes among patients with locally advanced gastric cancer. Data from a multicenter …

Background The relation between gastric cancer characteristics and lymph node (LN)
metastatic patterns is not fully clear, especially following neoadjuvant chemotherapy (NAC) …

Objective: To compare postoperative outcomes of minimally invasive gastrectomy (MIG) to
open gastrectomy (OG) for cancer during the introduction of MIG in the Netherlands …

Aim Insight in health-related quality of life (HRQoL) may improve clinical decision making
and inform patients about the long-term effects of gastrectomy. This study aimed to evaluate …

METHODS: An international cross-sectional survey on gastric cancer surgery was performed
amongst international upper gastro-intestinal surgeons. All surgical members of the …

Background Previous studies comparing laparoscopic‐assisted to open gastrectomy (OG)
for resectable gastric cancer were inexhaustive, so an updated meta‐analysis was …

Gastric cancer (GC) is the fifth malignancy and the third cause of cancer death worldwide,
according to the global cancer statistics presented in 2018. Its definition and staging have …